Brief: Calidi To Effect Reverse Stock Split
July 5 (Reuters) - Calidi Biotherapeutics Inc CLDI.A :
* CALIDI TO EFFECT REVERSE STOCK SPLIT
* CALIDI BIOTHERAPEUTICS INC - CALIDI COMMON STOCK EXPECTED
TO
BEGIN TRADING ON A 1-FOR-10 SPLIT ADJUSTED BASIS ON JULY 15,
2024
Source text for Eikon: ID:nBw356wT3a
Further company coverage: CLDI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma